PL434519A1 - Kompozycja aerozolowa do jamy ustnej - Google Patents

Kompozycja aerozolowa do jamy ustnej

Info

Publication number
PL434519A1
PL434519A1 PL434519A PL43451920A PL434519A1 PL 434519 A1 PL434519 A1 PL 434519A1 PL 434519 A PL434519 A PL 434519A PL 43451920 A PL43451920 A PL 43451920A PL 434519 A1 PL434519 A1 PL 434519A1
Authority
PL
Poland
Prior art keywords
weight
aerosol composition
oral hygiene
amount
composition
Prior art date
Application number
PL434519A
Other languages
English (en)
Other versions
PL244375B1 (pl
Inventor
Piotr Tutka
Anna Czerniecka-Kubicka
Karol Wróblewski
Patrycjusz Kołodziejczyk
Mateusz Bieniasz
Original Assignee
Uniwersytet Rzeszowski
Podkarpackie Centrum Innowacji Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Rzeszowski, Podkarpackie Centrum Innowacji Spółka Z Ograniczoną Odpowiedzialnością filed Critical Uniwersytet Rzeszowski
Priority to PL434519A priority Critical patent/PL244375B1/pl
Publication of PL434519A1 publication Critical patent/PL434519A1/pl
Priority to EP21182872.8A priority patent/EP3967298A1/en
Publication of PL244375B1 publication Critical patent/PL244375B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Addiction (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

Przedmiotem zgłoszenia jest kompozycja aerozolowa do jamy ustnej zawiera: cytyzynę w ilości od 0,01 do 10% masowych, hydrofilowy niejonowy emulgator z grupy kopolimerów lub polimerów w ilości od 0,1 do 10% masowych, co najmniej jeden alkohol w ilości od 0,01 do 40% masowych oraz składników pomocniczych i wody oczyszczonej w uzupełnieniu do 100% masowych, przy czym pH kompozycji wynosi od 7 do 10.
PL434519A 2020-06-30 2020-06-30 Kompozycja aerozolowa do jamy ustnej PL244375B1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL434519A PL244375B1 (pl) 2020-06-30 2020-06-30 Kompozycja aerozolowa do jamy ustnej
EP21182872.8A EP3967298A1 (en) 2020-06-30 2021-06-30 Aerosol composition for oral use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL434519A PL244375B1 (pl) 2020-06-30 2020-06-30 Kompozycja aerozolowa do jamy ustnej

Publications (2)

Publication Number Publication Date
PL434519A1 true PL434519A1 (pl) 2021-05-04
PL244375B1 PL244375B1 (pl) 2024-01-22

Family

ID=75723251

Family Applications (1)

Application Number Title Priority Date Filing Date
PL434519A PL244375B1 (pl) 2020-06-30 2020-06-30 Kompozycja aerozolowa do jamy ustnej

Country Status (2)

Country Link
EP (1) EP3967298A1 (pl)
PL (1) PL244375B1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4420664A1 (en) 2023-02-27 2024-08-28 Adamed Pharma S.A. Pharmaceutical composition comprising cytisine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101428021B (zh) 2007-11-09 2012-07-18 江苏中康药物科技有限公司 一种用于戒除烟瘾酒瘾的外用药物制剂
ES2592882T3 (es) 2008-10-14 2016-12-02 Mcneil Ab Forma de dosificación intra-oral de múltiples porciones y uso de la misma
CN103284319A (zh) 2013-06-20 2013-09-11 昌宁德康生物科技有限公司 一种金雀花碱替代尼古丁口腔雾化液及其制备方法
PL409829A1 (pl) 2014-10-18 2016-04-25 Łukasz Zalewski Płyn z cytyzyną do elektronicznych papierosów
RU2593585C1 (ru) * 2015-06-26 2016-08-10 Общество с ограниченной ответственностью "Ритек-Фарма" Способ лечения табакокурения и других форм никотиновой зависимости, а также профилактики рецидивов табакокурения
PL416496A3 (pl) * 2016-05-04 2017-11-06 Zalewski Piotr Stanisław Roztwór o działaniu farmakologicznym w terapii antynikotynowej do inhalacji za pomocą e-papierosów
EP3834814A1 (en) * 2019-12-10 2021-06-16 Adamed Pharma S.A. Liquid pharmaceutical composition comprising cytisine

Also Published As

Publication number Publication date
EP3967298A1 (en) 2022-03-16
PL244375B1 (pl) 2024-01-22

Similar Documents

Publication Publication Date Title
JP5568246B2 (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用点眼剤
HRP20050845A2 (en) Prostaglandin analogs as ep4 receptor antagonists
JP5941524B2 (ja) シリコーンハイドロゲルコンタクトレンズ用眼科組成物
US20140308368A1 (en) Ophthalmological aqueous composition
MA27318A1 (fr) Comprime de lasofoxifene et son enrobage
AR106776A1 (es) Composiciones de cuidado oral
PL434519A1 (pl) Kompozycja aerozolowa do jamy ustnej
JP2025074239A (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用点眼剤
ES2171440T3 (es) Composicion solida mucoadhesiva, terapeutica o higienica, para administracion por aplicacion sobre la mucosa bucal o nasal.
JP2015091835A (ja) シリコーンハイドロゲルコンタクトレンズ用眼科組成物
JP2014210813A (ja) シリコーンハイドロゲルコンタクトレンズ用点眼剤
JP5959271B2 (ja) 粘膜適用組成物
MX2023004677A (es) Moduladores de la via de respuesta integrada al estres.
RU2510264C1 (ru) Офтальмологический препарат в виде глазных капель, содержащий разветвленные полигексаметиленгуанидины
JP2012106963A (ja) マスク用組成物及びその使用方法
EP2314283A1 (en) Composition comprising anisic acid and an acid buffer
JP5846716B2 (ja) ソフトコンタクトレンズ用眼科組成物
MX2021015776A (es) Composiciones farmaceuticas en la forma de gel que contienen xiloglucano y alcoholes para la liberacion controlada de principios activos.
AU2013404932B2 (en) Preservative system
JPH04305504A (ja) 粘稠状殺菌剤組成物
JPH0314512A (ja) 歯垢付着抑制口腔用組成物
JP2008115125A (ja) 消毒用速乾性透明ローション
JP5999981B2 (ja) 保存安定性に優れたステイン形成阻害用液体口腔用組成物
PL443724A1 (pl) Kompozycja farmaceutyczna z flukonazolem o zwiększonej aktywności przeciwgrzybiczej, postać kompozycji farmaceutycznej oraz zastosowanie kompozycji farmaceutycznej
JP2812496B2 (ja) 歯垢付着抑制洗口剤